Can we refine the selection for adjuvant treatment in stage III colon cancer?

• Date : 20/06/2018
• 3    
  0

Debate: Optimal therapy for patients with resectable pancreatic cancer - Surgery plus adjuvant chemo

• Date : 20/06/2018
• 2    
  0

New agents/strategies on the horizon in bile duct cancer

• Date : 20/06/2018
• 2    
  0

What is new in anal cancer in the last 12 months?

• Date : 20/06/2018
• 2    
  0

Metastatic gastric cancer: New targeted agents in metastatic gastric cancer

• Date : 20/06/2018
• 2    
  0

Discussion of colorectal cancer abstracts presented at ESMO GI

• Date : 20/06/2018
• 1    
  0

How can we deal with the explosion of new treatments? - FDA

• Date : 20/06/2018
• 0    
  0

Debate: Is multiparametric MRI is the holy grail for organ preservation in rectal cancer? - No

• Date : 20/06/2018
• 0    
  0

Rectal cancer after neoadjuvant therapy with complete clinical response - Surgery

• Date : 20/06/2018
• 0    
  0

Rectal cancer after neoadjuvant therapy with complete clinical response - Watchful waiting

• Date : 20/06/2018
• 0    
  0

Evolution and innovations in rectal cancer surgery

• Date : 20/06/2018
• 0    
  0

How to approach the patient with a BRAF mutant tumor

• Date : 20/06/2018
• 0    
  0

Current status and perspectives on liquid biopsies in GI cancer

• Date : 20/06/2018
• 0    
  0

Is broad NGS testing useful in patients with metastatic colorectal cancer? - Pro

• Date : 20/06/2018
• 0    
  0

Highlights of Posters at ESMO GI on colorectal cancer

• Date : 20/06/2018
• 0    
  0

What do the new evolutions in GI cancer mean for my practice? - South America

• Date : 20/06/2018
• 0    
  0

What do the new evolutions in GI cancer mean for my practice? - Middle East

• Date : 20/06/2018
• 0    
  0

Keynote Lecture: Understanding relevant immune mechanisms in GI oncology

• Date : 20/06/2018
• 0    
  0

How can we deal with the explosion of new treatments? - EMA

• Date : 20/06/2018
• 0    
  0

How can we deal with the explosion of new treatments? - ESMO

• Date : 20/06/2018
• 0    
  0

Selecting the optimal first-line treatment in advanced colorectal cancer

• Date : 20/06/2018
• 0    
  0

Explaining the unexplainable: CALGB vs FIRE-3 discrepant data

• Date : 20/06/2018
• 0    
  0

The left versus right colon cancer story: What is the truth?

• Date : 20/06/2018
• 0    
  0

How to improve on the outcome in RAS mutant tumors

• Date : 20/06/2018
• 0    
  0

Can we refine the selection for adjuvant treatment in stage II colon cancer?

• Date : 20/06/2018
• 0    
  0

Celebration Lecture: The history of GI cancer: What has been achieved over the last 20 years?

• Date : 20/06/2018
• 0    
  0

Locally advanced GE junction cancer - CRT

• Date : 20/06/2018
• 0    
  0

Are we making progress in surgery of the pancreas?

• Date : 20/06/2018
• 0    
  0

Debate: Optimal therapy for patients with resectable pancreatic cancer - Neoadjuvant chemotherapy

• Date : 20/06/2018
• 0    
  0

Debate: Adjuvant treatment of pancreatic cancer - Monotherapy

• Date : 20/06/2018
• 0    
  0

Improving the outcome of patients with metastatic pancreatic cancer

• Date : 20/06/2018
• 0    
  0

Evaluating predictive markers and subgroups in clinical trials: Caution and best practices

• Date : 20/06/2018
• 0    
  0

Clinical interpretation and validity of clinical trials: When do they become practice changing?

• Date : 20/06/2018
• 0    
  0

What to use and to improve the evaluation of responses - The role of PET/CT in functional imaging

• Date : 20/06/2018
• 0    
  0

What to use and to improve the evaluation of responses - The role of MRI in functional imaging

• Date : 20/06/2018
• 0    
  0

Management of squamous cell cancer for the esophagus - Neoadjuvant therapy followed by surgery

• Date : 20/06/2018
• 0    
  0

Management of squamous cell cancer for the esophagus - Definitive CRT

• Date : 20/06/2018
• 0    
  0

Keynote Lecture: TME surgery as seen by the creator

• Date : 20/06/2018
• 0    
  0

Locally advanced GE junction cancer - Peri-operative CT

• Date : 20/06/2018
• 0    
  0

Is FLOT the only standard in the perioperative setting for gastric cancer?

• Date : 20/06/2018
• 0    
  0

Keynote Lecture: Progress in unraveling the molecular taxonomy in oesophageal and gastric cancer

• Date : 20/06/2018
• 0    
  0

Keynote Lecture: Hereditary aspects of gastric cancer

• Date : 20/06/2018
• 0    
  0

Metastatic gastric cancer: Where are we with check-point inhibitors in gastric cancer?

• Date : 20/06/2018
• 0    
  0

What is new in GIST in the last 12 months?

• Date : 20/06/2018
• 0    
  0

What is new in bile duct cancer in the last 12 months?

• Date : 20/06/2018
• 0    
  0

Late treatment lines in colorectal cancer: any progress?

• Date : 20/06/2018
• 0    
  0

Genetics in pancreatic cancer: Implications for clinical practice

• Date : 20/06/2018
• 0    
  0

Keynote Lecture: Coping with escalating healthcare costs in 2018 and beyond

• Date : 20/06/2018
• 0    
  0

UEG Week 2025

• Date : 04/10/2025
• 847    
  0

Americas Hepato-Pancreato-Biliary Association Annual Meeting - AHPBA 2025

• Date : 20/03/2025
• 3078    
  0

Eus Endos International Live Cours 2024

• Date : 19/09/2024
• 2811    
  0

VirtualEndo24 - The Global View 2024

• Date : 04/07/2024
• 7656    
  0

BSG LIVE’24

• Date : 17/06/2024
• 6474    
  0